Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for April 14th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 14th:

Apollo Endosurgery, Inc. (APEN - Free Report) : This medical technology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

Apollo Endosurgery’s shares gained 23.3% over the last one month above the S&P 500’s increase of 1.9%. The company possesses a Momentum Score of B.

Aquestive Therapeutics, Inc. (AQST - Free Report) : This specialty pharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.

Aquestive Therapeutics’ shares gained 72% over the last one month. The company possesses a Momentum Score of B.

Fate Therapeutics, Inc. (FATE - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.

Fate Therapeutics’ shares gained 31.4% over the last one month. The company possesses a Momentum Score of B.

Mersana Therapeutics, Inc. (MRSN - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 60 days.

Mersana Therapeutics’ shares gained 52.1% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

The Hottest Tech Mega-Trend of All                

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>